Inovio Pharmaceuticals INO
NASDAQ INO
$1.16 -0.05 (-4.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Cash from Financing Activities (2010 - 2026)

Updated

Inovio Pharmaceuticals (INO) posted Cash from Financing Activities of $17.16 million for Q2 2026, compared with -$34,777 a year earlier.

Analysis

Inovio Pharmaceuticals (INO) Cash from Financing Activities (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Inovio Pharmaceuticals was $70.17 million, up 127.8% year-over-year; for FY2025, it came in at $53.05 million, up 3.1% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -35.2% (FY2020 to FY2025).
  • In prior years, Inovio Pharmaceuticals' Cash from Financing Activities was $51.48 million in FY2024 (+930.5%), $5 million in FY2023 (-93.9%), $81.84 million in FY2022 (-61.3%) and $211.5 million in FY2021 (-54.5%).
  • Quarterly Cash from Financing Activities has run from a low of -$11.36 million in Q1 2024 to a high of $47.59 million in Q4 2021 over five years.
  • Over the past five years, the year-over-year decline in Cash from Financing Activities ranged from 5.4% (Q3 2024) to 93.3% (Q2 2023).
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $953,790 (Q1 2026), $27.13 million (Q4 2025) and $24.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -8.78 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -5.05 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -47.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 2.34 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -3.66 Bn
10 Inovio Pharmaceuticals 98.76 Mn 98.76 Mn - 17.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.16 Mn
Mar 31, 2026 953,790.00
Dec 31, 2025 27.13 Mn
Sep 30, 2025 24.92 Mn
Jun 30, 2025 -34,777.00
Mar 31, 2025 1.03 Mn
Dec 31, 2024 29.15 Mn
Sep 30, 2024 660,648.00
Jun 30, 2024 33.03 Mn
Mar 31, 2024 -11.36 Mn
Dec 31, 2023 1.84 Mn
Sep 30, 2023 698,633.00
Jun 30, 2023 2.88 Mn
Mar 31, 2023 -424,704.00
Dec 31, 2022 6.67 Mn
Sep 30, 2022 3.81 Mn
Jun 30, 2022 42.94 Mn
Mar 31, 2022 28.42 Mn
Dec 31, 2021 47.59 Mn
Sep 30, 2021 -440,780.00
API Access

Inovio Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INO&period=max&api_key=YOUR_API_KEY